Scored drug-market and company safety briefs from openFDA, FDA, BLS and ClinicalTrials.gov: recalls, adverse events, approvals, trial pipelines, shortages, device safety, warning letters and drug prices, for the US market and for Pfizer, Lilly and J&J. Each is a 0-100 score with drivers and citations. POST /v1/brief with {vertical}. Research signal, not medical or investment advice.

Payment Options